All questionsDrug interactions: Wegovy (semaglutide), all indications2 questions · 1 sourceDrug interactionsWhat drug interactions does Wegovy have?“WEGOVY® lowers blood glucose and can cause hypoglycemia. The risk of hypoglycemia is increased when WEGOVY® is used concomitantly with insulin or insulin secretagogues (e.g., sulfonylureas). The addition of WEGOVY® in patients treated with insulin has not been evaluated. When initiating WEGOVY®, consider reducing the dose of concomitantly administered insulin secretagogue or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions (5.4), Adverse Reactions (6.1)].” (opens the source at this quote in a new tab)CopyFlag“WEGOVY® causes a delay of gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications. In clinical pharmacology trials with semaglutide 1 mg once weekly injection, semaglutide did not affect the absorption of orally administered medications [see Clinical Pharmacology (12.3)]. In a drug interaction study with the semaglutide tablet, levothyroxine exposure was increased 33% (90% CI: 1.25-1.42). Monitor the effects of oral medications concomitantly administered with WEGOVY®. Consider increased clinical or laboratory monitoring for medications that have a narrow therapeutic index or that require clinical monitoring.” (opens the source at this quote in a new tab)CopyFlag“In Vitro Studies: Semaglutide has very low potential to inhibit or induce CYP enzymes, and to inhibit drug transporters.” (opens the source at this quote in a new tab)CopyFlagDoes Wegovy make birth control pills less effective?“Clinical Studies and Model-Informed Approaches: The delay of gastric emptying with semaglutide may influence the absorption of concomitantly administered oral drugs [see Drug Interactions (7.2)]. Trials were conducted to study the potential effect of semaglutide on the absorption of oral drugs taken with semaglutide tablets administered orally at steady-state exposure. • Levothyroxine: Total thyroxine (i.e., adjusted for endogenous levels) AUC of was increased by 33% following administration of a single dose of levothyroxine 600 mcg concomitantly administered with oral semaglutide. Maximum exposure (Cmax) was unchanged. • Other Drugs: No clinically significant differences in semaglutide pharmacokinetics were observed when used concomitantly with omeprazole. No clinically significant differences in the pharmacokinetics of the following drugs were observed when used concomitantly with semaglutide: lisinopril, S-warfarin, R-warfarin, metformin, digoxin, ethinyl estradiol, levonorgestrel, furosemide or rosuvastatin.” (opens the source at this quote in a new tab)CopyFlag“In clinical pharmacology trials with semaglutide 1 mg once weekly injection, semaglutide did not affect the absorption of orally administered medications [see Clinical Pharmacology (12.3)].” (opens the source at this quote in a new tab)CopyFlagNote: The first passage describes drug interaction trials with Wegovy tablets and the second trials with semaglutide 1 mg once-weekly injection.